143 related articles for article (PubMed ID: 27714485)
1. A Pilot Study of Fragile X Syndrome Screening in Pregnant Women and Women Planning Pregnancy: Implementation, Acceptance, Awareness, and Geographic Factors.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
J Genet Couns; 2017 Jun; 26(3):501-510. PubMed ID: 27714485
[TBL] [Abstract][Full Text] [Related]
2. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
[TBL] [Abstract][Full Text] [Related]
3. Implementation of fragile X syndrome carrier screening during prenatal diagnosis: A pilot study at a single center.
Xi H; Xie W; Chen J; Tang W; Deng X; Li H; Peng Y; Wang D; Yang S; Zhang Y; Duan R; Fang J; Wang H
Mol Genet Genomic Med; 2021 Jul; 9(7):e1711. PubMed ID: 34057320
[TBL] [Abstract][Full Text] [Related]
4. Maternal attitudes to newborn screening for fragile X syndrome.
Christie L; Wotton T; Bennetts B; Wiley V; Wilcken B; Rogers C; Boyle J; Turner C; Hansen J; Hunter M; Goel H; Field M
Am J Med Genet A; 2013 Feb; 161A(2):301-11. PubMed ID: 23303663
[TBL] [Abstract][Full Text] [Related]
5. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
[TBL] [Abstract][Full Text] [Related]
6. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
[TBL] [Abstract][Full Text] [Related]
8. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.
Musci TJ; Caughey AB
Am J Obstet Gynecol; 2005 Jun; 192(6):1905-12; discussion 1912-5. PubMed ID: 15970847
[TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
[TBL] [Abstract][Full Text] [Related]
11. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy: patterns of community and healthcare provider participation in a Victorian screening program.
Leibowitz R; Lewis S; Emery J; Massie J; Smith M; Delatycki M; Archibald A
Aust J Prim Health; 2022 Dec; 28(6):580-587. PubMed ID: 36192111
[TBL] [Abstract][Full Text] [Related]
12. Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.
Gabis LV; Gruber N; Berkenstadt M; Shefer S; Attia OL; Mula D; Cohen Y; Elizur SE
Cerebellum; 2016 Oct; 15(5):595-8. PubMed ID: 27312842
[TBL] [Abstract][Full Text] [Related]
13. Molecular fragile X screening in normal populations.
Spence WC; Black SH; Fallon L; Maddalena A; Cummings E; Menapace-Drew G; Bick DP; Levinson G; Schulman JD; Howard-Peebles PN
Am J Med Genet; 1996 Jul; 64(1):181-3. PubMed ID: 8826471
[TBL] [Abstract][Full Text] [Related]
14. Attitudes toward prenatal screening and testing for Fragile X.
Fanos JH; Spangner KA; Musci TJ
Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
[TBL] [Abstract][Full Text] [Related]
15. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
[TBL] [Abstract][Full Text] [Related]
16. Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines.
Johansen Taber K; Lim-Harashima J; Naemi H; Goldberg J
Mol Genet Genomic Med; 2019 Dec; 7(12):e1024. PubMed ID: 31694075
[TBL] [Abstract][Full Text] [Related]
17. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of prenatal population screening for fragile X syndrome.
Hollingsworth B; Harris A
Community Genet; 2005; 8(2):68-72. PubMed ID: 15925881
[TBL] [Abstract][Full Text] [Related]
19. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study.
Bailey DB; Berry-Kravis E; Gane LW; Guarda S; Hagerman R; Powell CM; Tassone F; Wheeler A
Pediatrics; 2017 Jun; 139(Suppl 3):S216-S225. PubMed ID: 28814542
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
Meryash DL
Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
